Back
Amylyx Pharmaceuticals Quote, Financials, Valuation and Earnings
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!
Sell
45
AMLX
Amylyx Pharmaceuticals
Last Price:
5.72
Seasonality Move:
6.44%
7 Day Trial
ALL ACCESS PASS
$
7
The Mysterious VC Firm Behind Nvidia's Secret Weapon
Details Here!Amylyx Pharmaceuticals Price Quote
$5.72
+0.08 (+1.42%)
(Updated: November 4, 2024 at 5:55 PM ET)
Amylyx Pharmaceuticals Key Stats
Sell
45
Amylyx Pharmaceuticals (AMLX)
is a Sell
Day range:
$5.41 - $5.80
52-week range:
$1.58 - $19.95
Dividend yield:
0%
P/E ratio:
8.06
P/S ratio:
1.30
P/B ratio:
1.47%
Volume:
1.3M
Avg. volume:
1.5M
1-year change:
-67.02%
Market cap:
$384M
Revenue:
$380.8M
EPS:
$-2.45
How Much Does Amylyx Pharmaceuticals Make?
-
How Much Are Amylyx Pharmaceuticals's Sales Annually?
AMLX Revenues are $380.8M -
How Much Profit Does Amylyx Pharmaceuticals's Make A Year?
AMLX net income is $49.3M
Is Amylyx Pharmaceuticals Growing As A Company?
Data Unavailable
Amylyx Pharmaceuticals Stock Price Performance
-
Did Amylyx Pharmaceuticals Stock Go Up Last Month?
Amylyx Pharmaceuticals share price went up by 84.31% last month -
Did AMLX's Share Price Rise Over The Last Year?
AMLX share price fell by -67.02% over the past 1 year
What Is Amylyx Pharmaceuticals 52-Week High & Low?
-
What Is Amylyx Pharmaceuticals’s 52-Week High Share Price?
Amylyx Pharmaceuticals has traded as high as $19.95 over the past 52 weeks -
What Is Amylyx Pharmaceuticals’s 52-Week Low Share Price?
Amylyx Pharmaceuticals has traded as low as $1.58 over the past 52 weeks
Amylyx Pharmaceuticals Price To Free Cash Flow
Data Unavailable
Is It Risky To Buy Amylyx Pharmaceuticals?
-
How Much Debt Does Amylyx Pharmaceuticals Have?
Total long term debt quarterly is $0 -
How Much Cash Does Amylyx Pharmaceuticals Have?
Cash and short term investments quarterly total is $309.8M -
What Is Amylyx Pharmaceuticals’s Book Value Per Share?
Book value per share is 3.84
Is Amylyx Pharmaceuticals Cash Flow Positive?
-
What Is AMLX Cash Flow From Operations?
Cash flow from operations (TTM) is -$58.7M -
What Is Amylyx Pharmaceuticals’s Cash Flow From Financing?
Cash flow from financing (TTM) is $1.3M -
What Is Amylyx Pharmaceuticals’s Cash Flow From Investing?
Cash flow from investing (TTM) is -$115.3M
Amylyx Pharmaceuticals Return On Invested Capital
-
Is Management Doing A Good Job?
AMLX return on invested capital is -45.47% -
What Is Amylyx Pharmaceuticals Return On Assets?
ROA measures how assets are converting to revenues and is -37.92% -
What Is AMLX Return On Equity?
ROE is a measure of profitability and is -45.47%
Amylyx Pharmaceuticals Earnings Date & Stock Price
-
What Is Amylyx Pharmaceuticals's Stock Price Today?
A single share of AMLX can be purchased today for 5.64 -
What Is Amylyx Pharmaceuticals’s Stock Symbol?
Amylyx Pharmaceuticals trades on the nasdaq under the ticker symbol: AMLX -
When Is Amylyx Pharmaceuticals’s Next Earnings Date?
The next quarterly earnings date for Amylyx Pharmaceuticals is scheduled on November 8, 2024 -
When Is AMLX's next ex-dividend date?
Amylyx Pharmaceuticals's next ex-dividend date is November 5, 2024 -
How To Buy Amylyx Pharmaceuticals Stock?
You can buy Amylyx Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
Amylyx Pharmaceuticals Competitors
-
Who Are Amylyx Pharmaceuticals's Competitors?
Below is a list of companies who compete with Amylyx Pharmaceuticals or are related in some way:
Amylyx Pharmaceuticals Dividend Yield
-
What Is AMLX Dividend Yield?
Amylyx Pharmaceuticals’s dividend yield currently is 0% -
What Is Amylyx Pharmaceuticals’s Payout Ratio?
Amylyx Pharmaceuticals’s payout ratio is 0% -
When Did Amylyx Pharmaceuticals Last Pay A Dividend?
The latest dividend pay date is November 5, 2024 -
What Is Amylyx Pharmaceuticals’s Dividend Per Share?
Amylyx Pharmaceuticals pays a dividend of $0.00 per share
Amylyx Pharmaceuticals Analyst Estimates
| YoY Growth | Past Surprise | |
|---|---|---|
| EPS: | 0% | 23.92% |
| Revenue: | 0% | -111.99% |
Analyst Recommendations
| Buy Recommendations: | 1 |
|---|---|
| Hold Recommendations: | 5 |
| Sell Recommendations: | 0 |
| Price Target: | 5.33 |
| Downside from Last Price: | -5.44% |